92691 ⎘
Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
IRON REPLACEMENT TREATMENTS
#2Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light
#3Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
#4NOVEL AMINO ACID DERIVATIVES
#5COMPOUNDS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS
#6SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#7NUCLEIC ACID DELIVERY MATERIAL
#8GINGERENONE A PRODRUGS AS SENSOTHERAPEUTICS AND METHODS OF USE
#9Synthetic intermediates and improved processes for preparing ROCk inhibitors
#10SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#11BENZOATE DERIVATIVES
#12SESQUITERPENE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF
#13Benzoate derivatives
#14SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#15COMPOUNDS AND METHODS
#16SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#17Diamine derivatives as inhibitors of leukotriene Ahydrolase
#18Alkoxy compounds for disease treatment
#192,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS
#20MITOCHONDRIAL DYSFUNCTION IMPROVING AGENT
#21Compounds and methods for treatment of bacterial infections
#22QUATERNARY AMINE COMPOUNDS WITH ISOPROPYLMETHYLPHENOL ESTER MOIETIES AS ANTIVIRALS, ANTIBACTERIALS AND ANTIMYCOTICS
#23SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#24Compositions and methods of use for opioid hexadienoates and optionally substituted hexadienoates
#25Benzathine analogs
#26SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#27Lipids and lipid compositions for the delivery of active agents
#28Alkoxy compounds for disease treatment
#29SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#30Organic amine ester derivative drug of 2-(α-hydroxypentyl)benzoic acid
#31Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#32Inactivators of toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria
#33SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#34Self-oriented material, self-oriented liquid crystal material and manufacturing method of liquid crystal panel
#35Benzathine analogs
#36Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates
#37HIGH MOBILITY GROUP B1 PROTEIN INHIBITORS
#38SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#39Therapeutic agent for glaucoma
#40Alkoxy compounds for disease treatment
#41SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#42Benzathine analogs
#43Substituted phenyl aziridine precursor analogs for inhibiting androgen-independent prostate cancer cell growth
#44LSD1 inhibitors and uses thereof
#45Lipids and lipid compositions for the delivery of active agents
#46SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#47Methods for low temperature fluorine-18 radiolabeling of biomolecules
#48Potent phthalate inhibitors of aspartate N-acetyltransferase and selective aspartate pathway inhibitors
#49DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#50Adenylyl cyclase inhibitors for neuropathic and inflammatory pain
#51Compounds and compositions for delivery of nutrients and micronutrients to plants
#52Alkoxy compounds for disease treatment
#53Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase
#54INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#55Inactivators of ornithine aminotransferase for treating toxoplasmosis and malaria
#56Short acting phenylalkylamine calcium channel blockers and uses thereof
#57Short acting phenylalkylamine calcium channel blockers and uses thereof
#58Short acting phenylalkylamine calcium channel blockers and uses thereof
#59Tertiary amines for use in the treatment of cardiac disorders
#60ARYLALKYLAMINE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS
#61Compositions and methods relating to proliferative diseases
#62Resist composition and patterning process
#63Alkoxy compounds for disease treatment
#64Short acting phenylalkylamine calcium channel blockers and uses thereof
#65Lipids and lipid compositions for the delivery of active agents
#66Adenylyl cyclase inhibitors for neuropathic and inflammatory pain
#674-aminomethylbenzoic acid derivative
#68Benzathine analogs
#69FBXO3 inhibitors
#70Substituted naphthalene compounds as calcium sensing receptor modulators
#71Dendrimer Scaffolds for Pharmaceutical Use
#72Arylalkylamine compounds as calcium sensing receptor modulators
#73Short acting phenylalkylamine calcium channel blockers and uses thereof
#74Inhibitors of leukotriene A4 hydrolase
#75Quaternary ammonium salt compound, composition for forming a resist under layer film, and patterning process
#76Arylalkylamine compounds as calcium sensing receptor modulators
#77Alkoxy compounds for disease treatment
#78Dendrimer scaffolds for pharmaceutical use
#79Benzathine analogs
#80INDANE DIMERS FOR USE IN THE TREATMENT OF AUTOIMMUNE INFLAMMATORY DISEASE
#81Tertiary amines for use in the treatment of cardiac disorders
#82Bicyclic compound
#83Process for the preparation of optically pure fesoterodine derivatives
#84Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#85NOVEL SULFONATE-BASED TRIMEBUTINE SALTS
#86Pharmaceutical compounds
#87Amino photo-reactive binder
#88Photo-reactive binder
#89Compositions and methods relating to proliferative diseases
#90Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis, performances and applications
#91Short acting phenylalkylamine calcium channel blockers and uses thereof
#92Amorphous asiatic tromethamine salt and preparation method thereof
#93Compounds for use in the treatment of immune related inflammatory disease
#94Inhibitors of the shiga toxins trafficking through the retrograde pathway
#95Expression Modulator For Clock Gene
#96Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth
#97Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)
#98Crystalline forms of a 3-carboxypropyl-aminotetralin compound
#99Expression Modulator For Clock Gene
#100Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
#101Alkoxy compounds for disease treatment
#102Process for the synthesis of tapentadol and intermediates thereof
#103DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#104Antimicrobial agents
#105Crystalline forms of a 3-carboxypropyl-aminotetralin compound
#106Heterocyclic CETP inhibitors
#107Preparation method of 4-aminomethylbenzoic acid
#108Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#109Process for obtaining 3, 3-diphenylpropylamines
#110Alkoxy compounds for disease treatment
#111Composition, compound and film forming method
#112Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis, performances and applications
#113Compositions and methods relating to proliferative diseases
#114Alkoxy compounds for disease treatment
#115Alkoxy compounds for disease treatment
#116CALCIUM-SENSING RECEPTOR-ACTIVE COMPOUNDS
#117Crystalline forms of a 3-carboxypropyl-aminotetralin compound
#118Gamma-amino-butyric acid derivatives as GABAreceptor ligands
#119MODIFICATION I OF 4-(PHENYL)ETHYL]-AMINO}METHYL)BENZOIC ACID
#120Monohydrate of 4-(phenyl)ethyl]-amino}methyl)benzoic acid
#121NOVEL SUBSTITUTED AMIDES, THEIR PREPARATION AND USE
#122Renin inhibitors
#123Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#124Process for the preparation of fesoterodine
#125PHOTORESIST COMPOSITION
#126Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis, performances and applications
#127NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES
#128SUBSTITUTED ARYL ALKYLAMINO-OXY-ANALOGS AND USES THEREOF
#129SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#130Gamma-amino-butyric acid derivatives as GABAreceptor ligands
#131Heterocyclic CETP inhibitors
#132Process for the Preparation of Fesoterodine
#133Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#134SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF
#135Process for the preparation of N,N′-bis(2-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid and its derivatives
#136Crystalline forms of a 3-carboxypropyl-aminotetralin compound
#137Alkoxy compounds for disease treatment
#138Synthesis of substituted hydroxymethyl phenols
#139Aromatic ether derivatives useful as thrombin inhibitors
#140Aminodicarboxylic acid derivatives having pharmaceutical properties
#141Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities
#1421,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors
#143Production of (R)- and (S)-4-(1-aminoethyl) benzoic acid methyl ester sulfate by lipase acylation of racemic 4-(1-aminoethyl) benzoic acid methyl ester and sulfuric acid precipitation
#144Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#145Preparation of levalbuterol hydrochloride
#146BLT2-mediated disease, BLT2 binding agent and the compound
#147Substituted amides, their preparation and use
#148Dicarboxylic acid derivatives with pharmaceutical properties
#149Levalbuterol hydrochloride Polymorph A
#150Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
#151Aryl aniline βadrenergic receptor agonists
#152Substituted aminodicarboxylic acid derivatives having pharmaceutical properties
#153Diamine derivatives as inhibitors of leukotriene Ahydrolase
#154Process for preparing methyl 4-(aminomethyl)benzoate
#155Calcium receptor modulating agents
#156Heterocyclic CETP inhibitors
#157Process for coupling benzylamines with haloaromatics
#158Calcium receptor-active molecules
#159Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis, performances and applications
#160Aryl aniline β2 adrenergic receptor agonists
#161Halogen-substituted aminodicarboxylic acid derivatives
#162Aminoalcohol derivatives
#163Aminodicarboxylic acid derivatives having pharmaceutical properties
#164Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis
#165Levalbuterol hydrochloride Polymorph A
#166Levalbuterol hydrochloride polymorph B
#167Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof
#168Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#169Aryl aniline βadrenergic receptor agonists
#170Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
#171Benzenedicarboxylic acid derivatives
#172Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
#173Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation
#174Calcium receptor modulating agents
#175Aminoalcohol derivatives
#176Calcium receptor antagonists
#177Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
#178Dual PPAR-delta and PPAR-gamma agonists
#179Dual PPAR-δ PPAR-γ agonists